BioNexus Gene Lab Corp
BGLC • NASDAQ
BioNexus Gene Lab Corp is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Su-Leng Tan, with a market cap of $5.3M.
Market Cap$5.3M
Employees30.0
CEOSu-Leng Tan
CountryMalaysia
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
BGL
BioNexus Gene Lab Corp FAQ
Common questions about BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is scheduled to report earnings for Q1 2026 on May 14, 2026.
BioNexus Gene Lab Corp has approximately 30 employees.